Testing effectiveness (Phase 2)Study completedNCT01271725
What this trial is testing
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 74
Showing 20 of 305 results